Analogic Announces Results for the Fourth Quarter and Fiscal Year and Declares Quarterly Cash Dividend Medical Device Investing
FDA Approves 6-Month Primary End Point for the Lutonix® Below-the-Knee Drug Coated Balloon Medical Device Investing
